Fructosamine

An amino sugar formed when glucose non-enzymatically reacts with the N-terminal amino group of proteins. The fructose moiety is derived from glucose by the "classical" Amadori rearrangement.

Also Known As:

Networked: 755 relevant articles (33 outcomes, 100 trials/studies)

Relationship Network

Bio-Agent Context: Research Results

Experts

1.	Selvin, Elizabeth: 19 articles (09/2021 - 04/2011)
2.	Coresh, Josef: 11 articles (10/2019 - 04/2011)
3.	Islam, Md Shahidul: 9 articles (12/2019 - 12/2011)
4.	Steffes, Michael W: 5 articles (01/2014 - 04/2011)
5.	Nelson, R W: 5 articles (01/2012 - 07/2000)
6.	Gilor, Chen: 4 articles (07/2022 - 09/2010)
7.	Hammar, Niklas: 4 articles (01/2022 - 01/2013)
8.	Schwendenwein, Ilse: 4 articles (01/2022 - 12/2010)
9.	Ballantyne, Christie M: 4 articles (01/2020 - 04/2011)
10.	Sharrett, A Richey: 4 articles (01/2019 - 04/2014)

Related Diseases

1.	Body Weight (Weight, Body) 12/01/2011 - "Both exercise programs equally improved body weight and fructosamine levels however ART only partially decreased HOMA index compared with AT (ART: -25% vs AT: -54%, p<0.01). " 01/01/2021 - "An improvement in at least one lab parameter related to DM (mean BG, min BG, Fructosamine) and one clinical parameter (PU/PD, body weight) was achieved in 72% of dogs (80% of naive, 62% of pre-treated). " 04/01/2009 - "In the 47 cats completing the study, there were no significant differences in body weight or serum fructosamine concentrations at days 15 or 30 compared with day 0. " 10/19/2022 - "FD induced higher body weight and adiposity (both p < 0.0001), with higher fructosamine levels (p < 0.005) and a trend toward higher HOMA-β index (p = 0.05). " 12/01/2019 - "On days 0 and 32, serum fructosamine concentrations (SFCs), clinical scores, and body weights were determined. "
2.	Insulin Resistance 03/01/1996 - "Obtained results allow to ascertain, that regular aerobic exercise contributed to the growth of physical efficiency expressed by the VO2max value, reduction in fructosamine level in blood serum, increase in insulin sensitivity of erythrocyte receptor and improved effort tolerance related to glycemia." 10/02/2020 - "The homeostasis model assessment of insulin resistance level was significantly associated with the eAG/fPG ratio, but not with the ratio of GA to HbA1c, GA, HbA1c, and fructosamine levels. " 03/01/2012 - "2) To investigate associations between [fructosamine] at presentation in laminitic horses with a) single sample markers of insulin resistance and b) outcome. " 03/01/2012 - "Plasma fructosamine concentration may be higher amongst laminitic horses than normal horses; this might relate to underlying insulin resistance. " 02/01/2011 - "Fructosamine levels and the homeostasis model assessment of insulin resistance (HOMA-IR) index were increased, while there was a reduction in the HOMA-β (P < 0.05 for all vs. baseline). "
3.	Diabetes Mellitus 01/01/2023 - "Results: The study presents certain values of fructosamine over the level of changes in the state of patients with diabetes mellitus, reflecting the progress from the treatment in the compensation of carbohydrate metabolism, which allows creating a model of diagnostic values of the fructosamine levels, according to which the efficacy of treatment of diabetes mellitus, the state of progress of the disease in its compensation or decompensation are determined at a qualitative level. " 01/01/2023 - "The purpose of the study is to create a model for monitoring the efficacy of diabetes mellitus treatment by determining the fructosamine levels. " 01/01/2023 - "FRUCTOSAMINE VALUES IN MONITORING COMPENSATION AND EFFICACY OF DIABETES MELLITUS TREATMENT." 04/01/2023 - "The objective of this study was to determine the diagnostic performance of glycated haemoglobin (HbA1c) for canine diabetes mellitus (DM) and compare it with that of serum fructosamine. " 10/01/2021 - "Further evidence in the form of large-scale well-controlled studies is needed prior to recommending salivary fructosamine as a noninvasive diagnostic tool for glycemic status in patients with diabetes mellitus."
4.	Type 2 Diabetes Mellitus (MODY) 01/01/2002 - "CRLA increased the plasma concentration of LA over time in healthy subjects, and CRLA was safe, well tolerated, and effective in reducing plasma fructosamine in patients with type 2 diabetes." 02/01/2015 - "The aim of this study was to determine whether serum fructosamine is associated with the risk of type 2 diabetes mellitus (T2DM) in a cohort of middle-age Finnish men. " 11/01/2021 - "Increased valvular expression of NF-κB in diabetic individuals is associated not only with serum HbA1c and fructosamine levels but also with AVA and transvalvular gradient, indicating that strict long-term glycaemic control is needed in AS patients with concomitant type 2 diabetes. " 01/01/2019 - "HbA1c, FG, and fructosamine were measured in 203 adults from Senegal (100 control: 45 with type 2 diabetes (T2D); 103 SCT: 51 with T2D). " 02/01/2015 - "Serum fructosamine and risk of type 2 diabetes mellitus among middle-age Finnish men: a 23-year population-based prospective study."
5.	Glucose Intolerance 10/01/1993 - "This study demonstrated that a single measurement of either first or second generation fructosamine showed promise as a screening test for diabetes, but not impaired glucose tolerance, in older people." 01/01/1996 - "Elevation of serum fructosamine in these patients is consistent with the impaired glucose tolerance of uraemia. " 01/01/1994 - "[Role of the determination of serum fructosamine in the screening of glucose intolerance]." 01/01/1992 - "Thus, fructosamine determination is not sensitive enough to detect impaired glucose tolerance in asymptomatic women post partum. " 01/01/1992 - "Impaired glucose tolerance was found in 6 women (15%) of group I, and in one woman (2.5%) of group II. Fructosamine values were within the normal range in each of the seven women (1.74 + 0.2 mmol/l vs 1.73 + 0.2 mmol/l). "

Related Drugs and Biologics

1.	Glucose (Dextrose)
2.	Blood Glucose (Blood Sugar)
3.	Insulin (Novolin)
4.	Glycated Hemoglobin (Glycosylated Hemoglobin)
5.	1,5-anhydroglucitol
6.	Uric Acid (Urate)
7.	Amylases
8.	Albumins
9.	Triglycerides (Triacylglycerol)
10.	Lipids

Related Therapies and Procedures

1.	Therapeutics
2.	Glycemic Control
3.	Intra-Articular Injections
4.	Continuous Ambulatory Peritoneal Dialysis (CAPD)
5.	Renal Dialysis (Hemodialysis)